Albemarle Corp Files 2024 Annual Report
Ticker: ALB-PA · Form: 10-K · Filed: Feb 12, 2025 · CIK: 915913
| Field | Detail |
|---|---|
| Company | Albemarle CORP (ALB-PA) |
| Form Type | 10-K |
| Filed Date | Feb 12, 2025 |
| Risk Level | low |
| Pages | 14 |
| Reading Time | 17 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, financials
Related Tickers: ALB
TL;DR
ALB filed its 2024 10-K. All systems go.
AI Summary
Albemarle Corporation filed its annual report for the fiscal year ended December 31, 2024. The company is incorporated in Virginia and headquartered in Charlotte, North Carolina. Its common stock trades on the New York Stock Exchange under the symbol ALB. The filing indicates Albemarle is a well-known seasoned issuer and has met its filing requirements for the past 12 months and 90 days.
Why It Matters
This 10-K filing provides a comprehensive overview of Albemarle's financial performance and business operations for the fiscal year 2024, crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain new material information that would inherently increase risk.
Key Numbers
- 001-12658 — Commission file number (Identifies the company's filings with the SEC)
- 54-1692118 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- ALBEMARLE CORPORATION (company) — Registrant
- Virginia (jurisdiction) — State of incorporation
- Charlotte, North Carolina (location) — Principal executive offices
- ALB (stock_symbol) — Common Stock trading symbol
- ALB PR A (stock_symbol) — Preferred Stock trading symbol
- New York Stock Exchange (organization) — Exchange where securities are registered
- December 31, 2024 (date) — Fiscal year end
FAQ
What is Albemarle Corporation's primary business?
The filing does not explicitly state Albemarle's primary business, but it lists its common stock and preferred stock trading on the New York Stock Exchange.
Where is Albemarle Corporation headquartered?
Albemarle Corporation's principal executive offices are located at 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209.
What is the trading symbol for Albemarle Corporation's common stock?
The trading symbol for Albemarle Corporation's common stock is ALB.
Has Albemarle Corporation filed all required reports for the past 12 months?
Yes, the filing indicates that Albemarle Corporation has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months.
What is the par value of Albemarle Corporation's common stock?
The par value of Albemarle Corporation's common stock is $.01.
Filing Stats: 4,335 words · 17 min read · ~14 pages · Grade level 14.5 · Accepted 2025-02-12 17:09:12
Filing Documents
- alb-20241231.htm (10-K) — 3825KB
- exhibit311231202410-k.htm (EX-3.1) — 360KB
- exhibit4131231202410-k.htm (EX-4.13) — 409KB
- exhibit10301231202410-k.htm (EX-10.30) — 111KB
- exhibit191231202410-k.htm (EX-19) — 78KB
- exhibit2111231202410-k.htm (EX-21.1) — 53KB
- exhibit2311231202410-k.htm (EX-23.1) — 2KB
- exhibit3111231202410-k.htm (EX-31.1) — 10KB
- exhibit3121231202410-k.htm (EX-31.2) — 10KB
- exhibit3211231202410-k.htm (EX-32.1) — 5KB
- exhibit3221231202410-k.htm (EX-32.2) — 5KB
- alb-20241231_g1.jpg (GRAPHIC) — 78KB
- alb-20241231_g2.jpg (GRAPHIC) — 110KB
- alb-20241231_g3.jpg (GRAPHIC) — 83KB
- alb-20241231_g4.jpg (GRAPHIC) — 78KB
- alb-20241231_g5.jpg (GRAPHIC) — 78KB
- alb-20241231_g6.jpg (GRAPHIC) — 652KB
- alb-20241231_g7.jpg (GRAPHIC) — 38KB
- alb-20241231_g8.jpg (GRAPHIC) — 371KB
- image_0.jpg (GRAPHIC) — 4KB
- image_0a.jpg (GRAPHIC) — 0KB
- image_1.jpg (GRAPHIC) — 0KB
- 0000915913-25-000026.txt ( ) — 25427KB
- alb-20241231.xsd (EX-101.SCH) — 119KB
- alb-20241231_cal.xml (EX-101.CAL) — 148KB
- alb-20241231_def.xml (EX-101.DEF) — 721KB
- alb-20241231_lab.xml (EX-101.LAB) — 1369KB
- alb-20241231_pre.xml (EX-101.PRE) — 1085KB
- alb-20241231_htm.xml (XML) — 3760KB
Business
Business 3 Item 1A.
Risk Factors
Risk Factors 9 Item 1B. Unresolved Staff Comments 30 Item 1C. Cybersecurity 30 Item 2.
Properties
Properties 31 Item 3.
Legal Proceedings
Legal Proceedings 54 Item 4. Mine Safety Disclosures 54 Executive Officers of the Registrant 55 PART II Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 56 Item 6. [Reserved] 57 Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 57 Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 84 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data 86 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 143 Item 9A.
Controls and Procedures
Controls and Procedures 143 Item 9B. Other Information 143 Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections 143 PART III Item 10. Directors, Executive Officers and Corporate Governance 144 Item 11.
Executive Compensation
Executive Compensation 144 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 144 Item 13. Certain Relationships and Related Transactions, and Director Independence 144 Item 14. Principal Accountant Fees and Services 144 PART IV Item 15. Exhibits and Financial Statement Schedules 145 Item 16. Form 10-K Summary 151
Signatures
Signatures 152 Albemarle Corporation and Subsidiaries PART I
Business
Item 1. Business. Albemarle Corporation was incorporated in Virginia in 1993. Our principal executive offices are located at 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209. Unless the context otherwise indicates, the terms "Albemarle," "we," "us," "our" or "the Company" mean Albemarle Corporation and its consolidated subsidiaries. Albemarle is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. Our purpose is to enable a more resilient world. We partner to pioneer new ways to move, power, connect, and protect. The end markets we serve include grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical devices. We believe that our world-class resources with reliable and consistent supply, our leading process chemistry, high-impact innovation, customer centricity and focus on people and planet will enable us to maintain a leading position in the industries in which we operate. We and our joint ventures currently operate more than 25 production and research and development ("R&D") facilities, as well as a number of administrative and sales offices, around the world. As of December 31, 2024, we served approximately 1,900 customers in approximately 70 countries. For information regarding our unconsolidated joint ventures, see Note 8, "Investments," to our consolidated financial statements included in Part II, Item 8 of this report. Effective November 1, 2024, we transitioned our operating structure from two core global business units - Energy Storage and Specialties - to a fully integrated functional model designed to increase agility, deliver significant cost savings and maintain long-term competitiveness. In addition, our Ketjen business continues to be operated under a separate, wholly-owned subsidiary. We will continue to report results across three existing operating segments: Energy Storage, Speci